These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
370 related items for PubMed ID: 12678238
21. Development of a cell culture assay for the quantitative determination of vaccination-induced antibodies in rabbit sera against Clostridium perfringens epsilon toxin and Clostridium novyi alpha toxin. Borrmann E, Schulze F, Cussler K, Hänel I, Diller R. Vet Microbiol; 2006 Apr 16; 114(1-2):41-50. PubMed ID: 16361070 [Abstract] [Full Text] [Related]
22. Production and characterisation of a candidate hyper-immune serum for the replacement of the Bordetella pertussis mouse antiserum Biological Reference Preparation. Morgeaux S, Bornstein N, Mourton-Gilles C, Chagnaud P, Charbonneau J, Maurin J, Daas A, Variot P, Behr-Gross ME. Pharmeur Bio Sci Notes; 2020 Apr 16; 2020():141-160. PubMed ID: 32788037 [Abstract] [Full Text] [Related]
23. Development of monoclonal antibodies suitable for use in antigen quantification potency tests for clostridial veterinary vaccines. Hauer PJ, Clough NE. Dev Biol Stand; 1999 Apr 16; 101():85-94. PubMed ID: 10566780 [Abstract] [Full Text] [Related]
25. Collaborative study for the establishment of the WHO 3(rd) International Standard for Endotoxin, the Ph. Eur. endotoxin biological reference preparation batch 5 and the USP Reference Standard for Endotoxin Lot H0K354. Findlay L, Desai T, Heath A, Poole S, Crivellone M, Hauck W, Ambrose M, Morris T, Daas A, Rautmann G, Buchheit KH, Spieser JM, Terao E. Pharmeur Bio Sci Notes; 2015 Apr 16; 2015():73-98. PubMed ID: 26830160 [Abstract] [Full Text] [Related]
26. [Development of in vitro methods for the potency testing of clostridial vaccines]. Borrmann E, Schulze F, Diller R. ALTEX; 2001 Apr 16; 18(1):34-6. PubMed ID: 11248848 [Abstract] [Full Text] [Related]
27. Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for serological potency testing of tetanus vaccines for human use: Clostridium tetani guinea pig antiserum (human). Hendriksen C, van der Gun J, Winsnes R, Urdal T, Rautmann G, Esposito-Farese ME. Pharmeuropa Spec Issue Biol; 2001 Aug 16; 2001(1):7-11. PubMed ID: 11705101 [No Abstract] [Full Text] [Related]
28. Serological assays as alternatives to the Ph Eur challenge test for batch release of tetanus vaccines for human use. Winsnes R, Hendriksen C, Sesardic D, Akkermans A, Daas A. Dev Biol Stand; 1999 Aug 16; 101():277-88. PubMed ID: 10566802 [Abstract] [Full Text] [Related]
29. Establishment of European Pharmacopoeia (Ph. Eur.) Biological Reference Preparations (BRP) batch 2 for rDNA hepatitis B vaccine (method A and B). Dobbelaer R, Daas A, Milne C. Pharmeuropa Bio; 2004 Jan 16; 2003(2):77-90. PubMed ID: 14960264 [Abstract] [Full Text] [Related]
30. An in vitro alternative to the mouse neutralisation assay for potency testing of betatoxoid containing Clostridium, perfringens type B and type C vaccines for veterinary use. Ebert E, Kusch M, Öppling V, Werner E, Cussler K. ALTEX; 1996 Jan 16; 13(2):68-75. PubMed ID: 11178445 [Abstract] [Full Text] [Related]
31. Establishment of European Pharmacopoeia BRP batch 2 for inactivated poliomyelitis vaccine for in vitro D antigen assay. Fuchs F, Minor P, Daas A, Milne C. Pharmeuropa Bio; 2003 Jul 16; 2003(1):23-50. PubMed ID: 14563307 [Abstract] [Full Text] [Related]
32. Establishment of a candidate equine influenza Florida Clade 2 strain A/eq/Richmond/1/07 horse antiserum as Ph. Eur. Biological Reference Preparation/OIE International Reference Reagent. Paillot R, Regourd E, Behr-Gross ME. Pharmeur Bio Sci Notes; 2020 Jul 16; 2020():125-140. PubMed ID: 32677612 [Abstract] [Full Text] [Related]
33. Replacement of the Toxin Neutralisation Test in Mice by in vitro Serological Assay Systems for Potency Testing of Tetanus Toxoid Vaccines for Veterinary Use: Results of a European Collaborative Study. Hendriksen CF. ALTEX; 1994 Jul 16; 11(5):30-34. PubMed ID: 11178404 [Abstract] [Full Text] [Related]
34. An international collaborative study to replace the 1st international standard for prekallikrein activator. Longstaff C, Behr-Gross ME, Daas A, Lackner F. Vox Sang; 2005 Feb 16; 88(2):143-51. PubMed ID: 15720613 [Abstract] [Full Text] [Related]
35. International collaborative study to establish reference preparations to standardise haemagglutination testing for anti-A and anti-B in normal intravenous immunoglobulins by the direct method. Thorpe SJ, Fox B, Sharp G, Heath AB, Behr-Gross ME, Terao E, Virata-Theimer ML, Yu MW. Pharmeur Bio Sci Notes; 2010 Apr 16; 2010(1):39-50. PubMed ID: 20223189 [Abstract] [Full Text] [Related]
36. Veterinary vaccines: In-VITRO--International Veterinary Industry Test Replacement Organisation. Redhead K, Lucken R, van de Moer A, Houghton S, Simpson B, Cameron A, Monkton P, Hennesy K, Ellis C. Dev Biol Stand; 1999 Apr 16; 101():261-6. PubMed ID: 10566800 [Abstract] [Full Text] [Related]
37. Establishment of the Ph. Eur. BRP for varicella vaccine batch 1. Akkermans AM, Waeterloos G, Kemiha K, Daas A, Milne C. Pharmeur Bio Sci Notes; 2009 Oct 16; 2009(1):41-54. PubMed ID: 20144451 [Abstract] [Full Text] [Related]
38. Collaborative study for the establishment of a European Phamacopoeia Biological reference preparation for Bordetella pertussis mouse antiserum for serological potency testing of acellular pertussis vaccines. Poirier B, Bornstein N, Andre M, Marmonier D, Pares M, Vanhooren G, Rautmann G, Behr-Gross ME, Dobbelaer R, Fuchs F. Biologicals; 2003 Mar 16; 31(1):25-38. PubMed ID: 12623057 [Abstract] [Full Text] [Related]
39. Collaborative study for establishment of a European Pharmacopoeia Biological Reference Preparation (BRP) for B19 virus DNA testing of plasma pools by nucleic acid amplification technique. Nübling CM, Daas A, Buchheit KH. Pharmeuropa Bio; 2004 Jan 16; 2003(2):27-34. PubMed ID: 14960261 [Abstract] [Full Text] [Related]
40. Collaborative study for the validation of cell line assays for in-process toxicity and antigenicity testing of Clostridium septicum vaccine antigens - Part 2: Optimisation of cell line assays. Behr-Gross ME, Siklodi B, Le Tallec D, Halder M, Manou I, Sinitskaya N, Bruckner L, Dalmadi B, Kiss L, Redhead K. Pharmeur Bio Sci Notes; 2021 Jan 16; 2021():101-156. PubMed ID: 34078535 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]